Role of gamma interferon in a neonatal mouse model of group B streptococcal disease

Infection and Immunity

Volumn 64, Issue 8, 1996, Pages 2941-2944

  Cusumano, Vitaliano ^a   Mancuso, Giuseppe ^a   Genovese, Francesco ^b   Delfino, Demetrio ^a   Beninati, Concetta ^a   Losi, Elena ^b   Teti, Giuseppe ^a,c  

^a UNIVERSITY OF MESSINA   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

^c Istituto di Microbiologia   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; MONOCLONAL ANTIBODY; RECOMBINANT GAMMA INTERFERON; RECOMBINANT INTERLEUKIN 10; RECOMBINANT INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; BACTERIAL GROWTH; CONTROLLED STUDY; EXPERIMENTAL MODEL; IMMUNE RESPONSE; IMMUNOPHARMACOLOGY; MOUSE; NEWBORN; NEWBORN INFECTION; NEWBORN SEPSIS; NONHUMAN; PRIORITY JOURNAL; SPLEEN CELL; STREPTOCOCCUS AGALACTIAE; STREPTOCOCCUS INFECTION; SURVIVAL TIME;

EID: 0030054831     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.64.8.2941-2944.1996     Document Type: Article

References (37)

1. Allan, G., P. Bhattacherjee, C. D. Brook, N. G. Read, and A. J. Parke. 1985. Mycloperoxidase activity as a quantitative marker of polymorphonuclear leukocyte accumulation into an experimental myocardial infarct. The effect of ibuprofen on infarct size and polymorphonuclear leukocyte accumulation. J. Cardiovasc. Pharmacol. 7:1154-1160.
2. Bagby, G. J., K. J. Plessala, L. A. Wilson, J. J. Thompson, and S. Nelson. 1991. Divergent efficacy of antibody to tumor necrosis factor-α in intravascular and peritonitis models of sepsis. J. Infect. Dis. 163:83-88.
3. Baker, C. J. 1986. Group B streptococcal infections in newborns. N. Engl. J. Med. 314:1702-1708.
4. Berger, M. 1990. Complement deficiency and neutrophil dysfunction as risk factors for bacterial infection in newborns and the role of granulocyte transfusion in therapy. Rev. Infect. Dis. 12:S401-S409.
5. Chen, Y., A. Nakane, and T. Minagawa. 1989. Recombinant murine gamma interferon induces enhanced resistance to Listeria monocytogenes infection in neonatal mice. Infect. Imm. 57:2345-2349.
6. Christensen, R. D., T. E. Arper, and G. Rothstein. 1986. Granulocyte-macrophage progenitor cells in term and preterm neonates. J. Pediatr. 109:1047-1051.
7. 6a.Cusumanu, V., et al. Submitted for publication.
8. Doherty, G. M., J. R. Lange, H. N. Langstein, H. Alexander, C. M. Buresh, and J. A. Norton. 1992. Evidence for IFN-γ as a mediator of the lethality of endotoxin and tumor necrosis factor alpha. J. Immunol. 149:1666-1670.
9. Drapier, J. C., and J. Wietzerbin. 1991. IFN-γ reduces specific binding of tumor necrosis factor on murine macrophages. J. Immunol. 146:1198-1203.
10. Espevik, T., and J. Nissen-Meyer. 1986. A highly sensitive cell line WEHI 164 clone 13 for measuring cytotoxic factor/tumor necrosis factor from human monocytes. J. Immunol. Methods 95:99-102.
11. Farrar, M. A., and R. D. Schreiber. 1993. The molecular cell biology of Interferon-γ and its receptor. Annu. Rev. Immunol. 11:571-611.
12. Freudenberg, M. A., Y. Kumazawa, S. Meding, J. Langhorne, and C. Galanos. 1991. Gamma Interferon production in endotoxin-responder and non-responder mice during infection. Infect. Immun. 59:3484-3491.
13. Hadjiminas, D. J., K. M. McMasters, J. C. Peyton, M. D. Cook, and W. G. Cheadle. 1994. Passive immunization against tumor necrosis factor and interleukin-1 fails to reduce lung neutrophil sequestration in chronic sepsis. Shock 2(5):376-380.
14. Heinzel, F. P. 1990. The role of IFN gamma in the pathology of experimental endotoxemia. J. Immunol. 145:2920-2924.
15. Heremans, H., J. Van Damme, C. Dillen, R. Dijkmans, and A. Billiau. 1990. IFN gamma, a mediator of lethal lipopolysaccharide-induced Shwartzman-like shock reactions in mice. J. Exp. Med. 171:1853-1869.
16. Hill, H. R. 1993. Modulation of host defenses with interferon-γ in pediatrics. J. Infect. Dis. 167:523-528.
17. Hill, H. R., N. H. Augustin, and H. S. Jaffe. 1991. Human recombinant Interferon-γ enhances neonatal polymorphonuclear leukocyte activation and movement and increases free intracellular calcium. J. Exp. Med. 173:767-770.
18. Kohler, J., D. Heumann, G. Garotta, D. LeRoy, S. Bailat, C. Barras, J. D. Baungartner, and M. P. Glauser. 1993. IFN-γ involvement in the severity of gram-negative infections in mice. J. Immunol. 151:916-921.
19. Lewis, D. B., A. Larsen, and C. B. Wilson. 1986. Reduced interferons-γ mRNA levels in human neonates. J. Exp. Med. 163:1018-1023.
20. Lewis, D. B., C. C. Yu, J. Meyer, B. K. English, S. J. Kahn, and C. B. Wilson. 1991. Cellular and molecular mechanisms for reduced interleukin-4 and interferon-γ production by neonatal T cells. J. Clin. Invest. 87:194-200.
21. 19a.Mancuso, G., et al. Unpublished data.
22. Mancuso, G., G. Blandino, R. A. Merendino, P. Rocca, G. Teti, and J. A. Cook. 1994. Cross-tolerance between bacterial endotoxin and group B streptococcus in neonatal rats. J. Endotox. Res. 1:114-119.
23. Mancuso, G., V. Cusumano, J. A. Cook, E. Smith, F. Squadrito, G. Blandino, and G. Teti. 1994. Efficacy of tumor necrosis factor alpha and eicosanoid inhibitors in experimental models of neonatal sepsis. FEMS Immunol. Med. Microbiol. 9:49-54.
24. Mancuso, G., F. Tomasello, M. Migliardo, D. Delfino, J. Cochran, J. A. Cook, and G. Teti. 1994. Beneficial effects of interleukin-6 in neonatal mouse models of group B streptococcal disease. Infect. Immun. 62:4997-5002.
25. Mancuso, G., F. Tomasello, C. von Hunolstein, G. Orefici, and G. Teti. 1994. Induction of tumor necrosis factor alpha by the group- and type-specific polysaccharides from type III group B streptococci. Infect. Immun. 62:2748-2753.
26. Martin, T. R., C. E. Rubens, and C. B. Wilson. 1988. Lung antibacterial defense mechanisms in infant and adult rats: implications for the pathogenesis of group B streptococcal infections in the neonatal lung. J. Infect. Dis. 157:91-100.
27. Ozmen, L., M. Pericin, J. Hakimi, R. A. Chizzonite, M. Wysocka, G. Trinchieri, M. Gately, and G. Garotta. 1994. Interleukin 12, interferon-γ, and tumor necrosis factor-α are the key of generalized Shwartzman reaction. J. Exp. Med. 180:907-915.
28. Redmond, H. P., K. D. Chavin, J. S. Bromberg, and J. M. Daly. 1991 Inhibition of macrophage-activating cytokines is beneficial in the acute septic response. Ann. Surg. 214:502.
29. Rodewald, A. K., A. B. Onderdonk, H. B. Warren, and D. L. Kasper. 1992. Neonatal mouse model of group B streptococcal infection. J. Infect. Dis. 166:635-639.
30. 4 and interleukin-8 from human monocytes: neonates exhibit a diminished response. J. Infect. Dis. 172:420-426.
31. Silva, A. T., and J. Cohen. 1992. Role of Interferon-γ in experimental gram-negative sepsis. J. Infect. Dis. 166:331-335.
32. Tannenbaum, C. S., J. A. Major, and T. A. Hamilton. 1993. IFN-γ and lipopolysaccharide differentially modulate expression of tumor necrosis factor receptor mRNA in murine peritoneal macrophages. J. Immunol. 151:6833-6839.
33. Taylor, S., and Y. J. Bryson. 1985. Impaired production of gamma interferon by newborn cells in vitro is due to a functionally immature macrophage. J. Immunol. 134:1493-1497.
34. Teti, G., G. Mancuso, and F. Tomasello. 1993. Cytokine appearance and effects of anti-tumor necrosis factor alpha antibodies in a neonatal rat model of group B streptococcal infection. Infect. Immun. 61:227-233.
35. Wakasugi, N., and J. L. Virelizier. 1985. Defective IFN-γ production in the human neonate. Dysregulation rather than intrinsic abnormality. J. Immunol. 134:167-171.
36. Wilson, C. B. 1986. Immunologic basis for increased susceptibility of the neonate to infection. J. Pediatr. 108:111-116.
37. Wilson, C. B., J. Westall, L. Johnston, D. B. Lewis, S. K. Dower, and A. R. Alpert. 1986. Decreased production of interferon gamma by human neonatal cells. J. Clin. Invest. 77:860-867.